Factors Associated with Failure of Non-pharmacological Treatment in Smoking Cessation
Main Article Content
Abstract
Objective: To identify factors contributing to the failure of non-pharmacological treatment in smoking cessation. Methods: This prognostic factor research collected retrospective cohort data from the medical records of patients who received treatment at the Fahsai Clinic, Rangsit University, from June 18, 2014, to November 16, 2023. The inclusion criteria were: 1) aged 18 years or older, 2) being current smokers seeking treatment to reduce or quit smoking, and 3) treated with non-pharmacological methods. The study outcome was treatment failure, assessed after completing 6 months of therapy through a phone interview. The factors studied included: 1) general information, such as gender, health issues, having spouses, partners or children, use of alcohol or drugs, and 2) smoking behavior, such as accumulated cigarette consumption, severity of nicotine dependence as assessed using the Heaviness of Smoking Index, and readiness to quit smoking based on the Transtheoretical Model. Multivariable logistic regression was used for association analysis. Results: The sample consisted of 316 individuals, with 81.33% treatment failure rate. The majority were male (88.61%), with a median age of 21 years and interquartile range of 19-31 years, and having mild and moderate levels of nicotine dependence (47.83 and 44.82, respectively). Factors associated with treatment failure included: 1) severe nicotine dependence (OR: 15.13; 95% CI 1.36-168.62), 2) having readiness to quit in the contemplation stage (OR: 8.49; 95% CI 2.85-25.25), and 3) being female (OR: 3.90; 95% CI 1.14-13.35). Conclusion: Factors associated with treatment failure in non-pharmacological smoking cessation include severe nicotine dependence, having readiness to quit in the contemplation stage, and being female. Patients with these factors should receive pharmacological intervention for smoking cessation from the start of therapy.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Li RM, Dupree L, Doering P. Substance-related disorders II: alcohol, nicotine, and caffeine [online]. 2020 [cited Jan 9, 2025]. Available from: accesspharmacy.mhmedical.com/content.aspx?bookid=2577§ionid=223397102
Rungreunghiranya S. Clinical practice guidelines for the treatment of nicotine dependence in Thailand, Revised edition in 2022. Bangkok; Professional Network of Physicians in Tobacco Control; 2021.
Tobacco Control Research and Knowledge Manage- ment Center. The tobacco consumption situation in Thailand 2019. Bangkok: Mahidol University; 2020.
Tobacco Control Research and Knowledge Manage- ment Center. The tobacco consumption situation in Thailand 2022. Bangkok: Mahidol University; 2023.
Matichon. Moving forward with the ‘FahSai Clinic’ to help Thais quit smoking and expand services to communities [online]. 2020 [cited Jan 9, 2025]. Available from: www.matichon.co.th/news-monitor/ news_2269946.
Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement. JAMA 2021; 325: 265-79.
Tobacco Use and Dependence Guideline Panel. Treating tobacco use and dependence: 2008 update [online]. 2008 [cited Jan 9, 2025]. Available from: www.ncbi.nlm.nih.gov/books/NBK63943/.
Sherman JJ. Chapter 9. Smoking cessation [online]. 2013 [cited Jan 9, 2025]. Available from: access pharmacy.mhmedical.com/content.aspx?bookid=684§ionid=45145844
Dupree L, Li RM. Substance use disorders II: alcohol, nicotine, and caffeine [online]. 2021 [cited Jan 9, 2025]. Available from: accesspharmacy.mh medical.com/content.aspx?bookid=3097§ionid=267918626
National Drug Information. National list of essential medicines and evidence-based guidelines 2024 [online]. 2024 [cited Jan 9, 2025]. Available from: ndi.fda.moph.go.th/drug_national.
Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol. 2014; 77: 324-36.
Longyhore DS, Dombrowski SK. Smoking cessation [online]. 2020 [cited Jan 9, 2025]. Available from: accesspharmacy.mhmedical.com/content.aspx?bookid=3025§ionid=254110911
Zbikowski SM, Swan GE, McClure JB. Cigarette smoking and nicotine dependence. Med Clin N Am. 2005; 88: 1453-65.
Chatkin JM, Mariante de Abreu C, Haggsträm FM, Wagner MB, Fritscher CC. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies? Addiction 2004; 99: 778-84.
Caponnetto P, Polosa R. Common predictors of smoking cessation in clinical practice. Respir Med. 2008; 102: 1182-92.
Sornpaisarn B, Parvez N, Chatakan W, Thitiprasert W, Precha P, Kongsakol R, et al. Methods and factors influencing successful smoking cessation in Thailand: a case-control study among smokers at the community level. Tob Induc Dis. 2022; 20: 67.
Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2008; 34: 365-73.
Qiu D, Chen T, Liu T, Song F. Smoking cessation and related factors in middle-aged and older Chinese adults: evidence from a longitudinal study. Plos One 2020; 15: e0240806.
Kim Y, Cho WK. Factors associated with successful smoking cessation in Korean adult males: findings from a national survey. Iran J Public Health 2014; 43: 1486-96.
Monsó E, Campbell J, Tønnesen P, Gustavsson G, Morera J. Sociodemographic predictors of success in smoking intervention. Tob Control. 2001; 10: 165-9.
Lin B, Xie L, Xie X, Yan Y, Zhang L, Xiao L. Predictors for quitting smoking in smoking cessation clinics among female smokers in China. Tob Induc Dis 2023; 21: 26.
Zhu N, Lin S, Cao C, Xu N, Yu X, Chen X. Nomogram to predict successful smoking cessation in a Chinese outpatient population. Tob Induc Dis 2020; 18: 86.
Klemperer EM, Mermelstein R, Baker TB, Hughes JR, Fiore MC, Piper ME, et al. Predictors of smoking cessation attempts and success following motivation-phase interventions among people initially unwilling to quit smoking. Nicotine Tob Res 2020; 22: 1446-52.
Choi HS, Sohn HS, Kim YH, Lee MJ. Factors associated with failure in the continuity of smoking cessation among 6 month's smoking cessation success in the smoking cessation clinic of public health center. Journal of the Korea Academia-Industrial Cooperation Society. 2012; 13: 4653-9.
Irfan M, Haque A, Shahzad H, Samani Z, Awan S, Khan J. Reasons for failure to quit: A cross-sectional survey of tobacco use in major cities in Pakistan. Int J Tuberc Lung Dis 2016; 20: 673-8.
Esen AD, Soylem Y, Arica S, Belgin G, Gonultas N. Factors affecting success and abstinence within a smoking cessation clinic: A one-year follow-up study in Turkey. Tob Prev Cessation 2020; 6: 71.
Koçak ND, Aktürk Ü A. What factors influence non-adherence to the smoking cessation program? Turk Thorac J 2019; 20: 168-74.
Fu R, Schwartz R, Mitsakakis N, Diemert LM, O’Connor S, Cohen JE. Predictors of perceived success in quitting smoking by vaping: A machine learning approach. Plos One 2022; 17: e0262407.
Lai CC, Huang WH, Chang BC, Hwang LC. Development of machine learning models for prediction of smoking cessation outcome. Int. J. Environ. Res Public Health 2021; 18: 2584.
Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ 2020; 368: m441.
Sherman JJ. Chapter 3. Counseling and motiva- tional interviewing [online]. 2013 [cited Jan 9, 2025]. Available from: accesspharmacy.mhmedical.com/ content.aspx?bookid=684§ionid=45145838
Raihan N, Cogburn M. Stages of change theory [online]. 2024 [cited Jan 9, 2025]. Available from: www.ncbi.nlm.nih.gov/books/NBK556005/.
Tseng MF, Huang CC, Tsai SC, Tsay MD, Chang YK, Juan CL, et al. Promotion of smoking cessation using the Transtheoretical Model: short-term and long-term effectiveness for workers in coastal central Taiwan. Tob Use Insights 2022; 15: 1179173x2211 04410.
Zhu N, Lin S, Dai L, Yu H, Xu N, Huang W, et al. Abrupt versus gradual smoking cessation with pre-cessation varenicline therapy for Chinese treatment-seeking smokers: A retrospective, observational, cohort study. Tob Induc Dis 2022; 20: 29.
Hu Y, Xie J, Chang X, Chen J, Wang W, Zhang L, et al. Characteristics and predictors of abstinence among smokers of a smoking cessation clinic in Hunan China. Front Public Health 2021; 9: 615817.
Poole NL, Candel MJJM, Willemsen MC, van den Brand FA. Real-life effectiveness of smoking cessation delivery modes: a comparison against telephone counseling and the role of individual characteristics and health conditions in quit success. Nicotine Tob Res 2023; 26: 452-60.
NIDA CTN. Instrument: Fagerstrom test for nicotine dependence (FTND) [online]. 2014 [cited Jan 9, 2025]. Available from: cde.nida.nih.gov/instrument/ d7c0b0f5-b865-e4de-e040-bb89ad43202b.
Mugnaini M, Tessari M, Tarter G, Merlo Pich E, Chiamulera C, Bunnemann B. Upregulation of [3H] methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. Eur J Neurosci 2002; 16: 1633-46.
Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009; 49: 57-71.
Swartz SH, Hays JT. Office-based intervention for tobacco dependence. Med Clin N Am 2004; 88: 1623-41.
Borrelli B, Hogan JW, Bock B, Pinto B, Roberts M, Marcus B. Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav 2002; 16: 22-7.
European Network for Smoking and Tobacco Prevention. 2020 Guidelines for treating tobacco dependence [online]. 2020 [cited Jan 9, 2025]. Available from: ensp.network/2020-guidelines-eng lish-edition/.
U.S. Public Health Service. A clinical practice guideline for treating tobacco use and dependence: 2008 update: a US public health service report. Am J Prev Med 2008; 35: 158-76.
Centers for Disease Control and Prevention. A practical guide to help your patients quit using tobacco [online].2019 [cited Jan 9, 2025]. Available from: www.cdc.gov/tobacco/patient-care/pdfs/hcp-conversation-guide.pdf.
Rockville M. Clinical guidelines for prescribing pharmacotherapy for smoking cessation: Agency for Healthcare Research and Quality [online]. 2012 [cited Jan 9, 2025]. Available from: www.ahrq.gov/ prevention/guidelines/tobacco/prescrib.html.
Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309: 842-6.
Perkins KA. Smoking cessation in women. Special considerations. CNS Drugs. 2012; 15: 391-411.